ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms https://www.biorxiv.org/content/10.1101/2023.01.01.522017v1?med=mas
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms https://www.biorxiv.org/content/10.1101/2023.01.01.522017v1?med=mas